• 99 Organisations —
  • COVID-19 MedTech Industry Landscape by Sector
1. AbbVie
2. AbCellera
3. AIM ImmunoTech 1990
4. AI Therapeutics 2013
5. AlloVir 2013
6. Alnylam
7. Ansun Biopharma
8. Ascletis Pharma
9. Athersys 1995
10. Bayer
11. Beijing Defengrei Biotechnology (BDB)
12. Bellerophon Therapeutics 2009
13. Beroni Group 2014
14. BioAegis Therapeutics
15. Biocryst Pharma
16. Biogen 1978
17. CalciMedica Inc.
18. Capricor Therapeutics 2005
19. Celltrion Healthcare
20. Celularity 2017
21. Chongqing Sidemu Biotechnology Technology
22. Chugai Pharmaceutical
23. Cipla 1935
24. CNS Pharmaceuticals
25. Cocrystal Pharma 2004
26. Cynata Therapeutics
27. CytoDyn Inc.
28. Cytovia Therapeutics
29. Distributed Bio 2010
30. Eli Lilly
31. Emmaus Life Sciences
32. Ennaid Therapeutics
33. ETHRIS
34. EUSA Pharma
35. Fujifilm Holdings
36. Geneyx 2018
37. GigaGen 2010
38. Gilead Sciences Inc.
39. Green Cross LabCell
40. Grifols 1940
41. Impact BioMedical
42. Incyte Corp
43. InflaRx
44. Innocan
45. Izana Bioscience
46. Junshi Bioscience
47. Kamada 1990
48. Karyopharm Therapeutics
49. Kleo Pharmaceuticals
50. La jolla Pharmaceutical 1989
51. Life Matters 2016
52. LineaRx
53. Mabpharm
54. Macromoltek
55. Mallinckrodt
56. Mannin Research
57. Mateon Therapeutics
58. MediciNova 2000
59. Merck KGaA 1668
60. Mesoblast 2004
61. Moleculin Biotech
62. NanoViricides
63. Neurimmune Holding 2006
64. NeuroRx 2015
65. Novan 2008
66. Novartis
67. NovImmune
68. Novoteris
69. Onecell Medical 2017
70. Pepticom 2011
71. PharmaMar
72. Pharmstandard 2003
73. Pluristem Therapeutics 2003
74. PrimeCell Therapeutics
75. Q BioMed 2013
76. RedHill Biopharma
77. Regeneron Pharmaceuticals Inc.
78. Respinova 2008
79. Ridgeback Biotherapeutics
80. Roche Holding AG
81. SAB Biotherapeutics
82. Sanofi
83. SaNOtize
84. Shanghai Hengrui Pharmaceutical
85. Sorrento Therapeutics 2006
86. Staidson Biopharma
87. Stero BioTech
88. Synairgen Research
89. Takeda Pharmaceutical Company Ltd.
90. Takis Biotech
91. Teva Pharmaceuticals 0
92. Union Therapeutics
93. Vanda Pharma
94. Vero Biotech 2006
95. Vir Biotechnology Inc.
96. Windtree Therapeutics 1992
97. WPD Pharmaceuticals
98. WuXi Biologics
99. Zhejiang Hisun Pharmaceutical

«COVID-19 MedTech Industry Landscape by Sector»

  • — organisation
  • — investor and funding support bodies
  • — hubs and other organisation types

Industries

AI R&D Pharma (DPI)
AI for Longevity
Altered Signaling, Public
Biotechnology
CAR-T, Peptides and Proteins, Viral Vectors
CAR-T, Public
Cell Therapy, Public
FemTech
General Healthcare
Global Health Challenges
Healthcare
Investment Funds
Investor
Longevity
Longevity and HealthTech Governance Organisations
P4 Medicine
PharmTech
Pharma
Public, Regenerative Medicine
Public, Treatments
Reproductive Health & Contraception
Small&Large Molecules
Treatment Development
Treatments

test_custom_domain_2
© 2026